{"id":"https://openalex.org/W7225399443","doi":"https://doi.org/10.1161/circ.154.suppl_1.14878","title":"Abstract 14878: Outcomes of Hydralazine-Isosorbide Dinitrate Addition to Contemporary Quadruple Guideline-Directed Medical Therapy in HFrEF: A TriNetX Propensity-Matched Landmark Analysis","display_name":"Abstract 14878: Outcomes of Hydralazine-Isosorbide Dinitrate Addition to Contemporary Quadruple Guideline-Directed Medical Therapy in HFrEF: A TriNetX Propensity-Matched Landmark Analysis","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225399443","doi":"https://doi.org/10.1161/circ.154.suppl_1.14878"},"language":"en","primary_location":{"id":"doi:10.1161/circ.154.suppl_1.14878","doi":"https://doi.org/10.1161/circ.154.suppl_1.14878","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.14878","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001954753","display_name":"Mohammed Najdat Seijari","orcid":"https://orcid.org/0000-0002-4778-1831","observed_orcids":["https://orcid.org/0000-0002-4778-1831"]},"institutions":[{"id":"https://openalex.org/I1312636312","display_name":"Good Samaritan Hospital","ror":"https://ror.org/03rj2a342","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1312636312","https://openalex.org/I4210150191"]},{"id":"https://openalex.org/I4210150191","display_name":"TriHealth","ror":"https://ror.org/04jpa5e08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed Najdat Seijari","raw_affiliation_strings":["TriHealth Good Samaritan Hosp, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TriHealth Good Samaritan Hosp, Cincinnati, OH","institution_ids":["https://openalex.org/I1312636312","https://openalex.org/I4210150191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161042597","display_name":"Fayaz A Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fayaz A Khan","raw_affiliation_strings":["Univ at Buffalo, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ at Buffalo, Buffalo, NY","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068983644","display_name":"Taraneh Zamani","orcid":"https://orcid.org/0009-0007-8281-0363","observed_orcids":["https://orcid.org/0009-0007-8281-0363"]},"institutions":[{"id":"https://openalex.org/I1312636312","display_name":"Good Samaritan Hospital","ror":"https://ror.org/03rj2a342","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1312636312","https://openalex.org/I4210150191"]},{"id":"https://openalex.org/I4210150191","display_name":"TriHealth","ror":"https://ror.org/04jpa5e08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taraneh Zamani","raw_affiliation_strings":["TriHealth Good Samaritan Hosp, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TriHealth Good Samaritan Hosp, Cincinnati, OH","institution_ids":["https://openalex.org/I1312636312","https://openalex.org/I4210150191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161050753","display_name":"Mohamad Fael","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamad Fael","raw_affiliation_strings":["Univ of Missouri-Kansas City, Kansas City, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Missouri-Kansas City, Kansas City, MO","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092729702","display_name":"Ankitha Vanaparti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150191","display_name":"TriHealth","ror":"https://ror.org/04jpa5e08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ankitha Vanaparti","raw_affiliation_strings":["TriHealth Heart and Vascular Institute, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TriHealth Heart and Vascular Institute, Cincinnati, OH","institution_ids":["https://openalex.org/I4210150191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055077682","display_name":"Nimrata Kumari","orcid":"https://orcid.org/0000-0002-9358-912X","observed_orcids":["https://orcid.org/0000-0002-9358-912X"]},"institutions":[{"id":"https://openalex.org/I39727005","display_name":"Dow University of Health Sciences","ror":"https://ror.org/01h85hm56","country_code":"PK","type":"education","lineage":["https://openalex.org/I39727005"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Nimrata Kumari","raw_affiliation_strings":["Dow Univ of Health Sciences, Karachi, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dow Univ of Health Sciences, Karachi, Pakistan","institution_ids":["https://openalex.org/I39727005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161028386","display_name":"Ma'in Abumuhfouz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ma'in Abumuhfouz","raw_affiliation_strings":["Univ of Missouri-Kansas City, Mission, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Missouri-Kansas City, Mission, KS","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161010809","display_name":"Mhd Baraa Habib","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Mhd Baraa Habib","raw_affiliation_strings":["Hamad Med Corp, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hamad Med Corp, Doha, Qatar","institution_ids":["https://openalex.org/I49828101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083257947","display_name":"Sateesh Kesari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150191","display_name":"TriHealth","ror":"https://ror.org/04jpa5e08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sateesh Kesari","raw_affiliation_strings":["TriHealth Heart and Vascular Institute, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TriHealth Heart and Vascular Institute, Cincinnati, OH","institution_ids":["https://openalex.org/I4210150191"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"154","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heart-failure-with-reduced-ejection-fraction","display_name":"heart failure with reduced ejection fraction","score":0.9980000257492065},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.7260000109672546},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.828000009059906},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.9710000157356262},{"id":"https://openalex.org/keywords/acute-heart-failure","display_name":"acute heart failure","score":0.9480000138282776},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9950000047683716},{"id":"https://openalex.org/keywords/syncope","display_name":"syncope","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.925000011920929},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6790000200271606},{"id":"https://openalex.org/keywords/angiotensin-receptor-neprilysin-inhibitors","display_name":"angiotensin receptor-neprilysin inhibitors","score":0.4860000014305115},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/mineralocorticoid-receptor-antagonists","display_name":"mineralocorticoid receptor antagonists","score":0.9229999780654907},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9810000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9695000052452087},{"id":"https://openalex.org/C2778949068","wikidata":"https://www.wikidata.org/wiki/Q179748","display_name":"Isosorbide dinitrate","level":2,"score":0.8998000025749207},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.6944000124931335},{"id":"https://openalex.org/C2994510025","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Medical therapy","level":2,"score":0.5911999940872192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43790000677108765},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40310001373291016},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3896999955177307},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.358599990606308},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.3495999872684479},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.3490999937057495},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3208000063896179},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.29750001430511475},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.28380000591278076},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.2718000113964081},{"id":"https://openalex.org/C3018047383","wikidata":"https://www.wikidata.org/wiki/Q817393","display_name":"Black female","level":2,"score":0.26969999074935913},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.26570001244544983},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.2653999924659729},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.251800000667572}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.154.suppl_1.14878","doi":"https://doi.org/10.1161/circ.154.suppl_1.14878","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.14878","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2269847225","https://openalex.org/W2737694634","https://openalex.org/W7095663667","https://openalex.org/W2890630993","https://openalex.org/W2735680200","https://openalex.org/W1931585512","https://openalex.org/W2063717493","https://openalex.org/W2050996604","https://openalex.org/W2505409267","https://openalex.org/W1997982303"],"abstract_inverted_index":{"Background:":[0],"Hydralazine-isosorbide":[1],"dinitrate":[2,101],"(H-ISDN)":[3],"is":[4],"guideline-recommended":[5],"for":[6,70],"self-identified":[7],"Black":[8,59,241,299],"patients":[9,111,186],"with":[10,43,48,74,83,110,193,201,214,233,255,266,278,288],"symptomatic":[11],"HFrEF,":[12,75],"but":[13,230,263],"pivotal":[14],"trials":[15],"predated":[16],"routine":[17],"ARNI":[18],"and":[19,26,91,99,125,139,179,209,221,273,295,310,354],"SGLT2":[20,92],"inhibitor":[21,93],"use.":[22],"Its":[23],"incremental":[24],"benefit":[25,303],"safety":[27],"after":[28,104,151,358],"contemporary":[29,281],"quadruple":[30,113,190,194,282,341],"guideline-directed":[31],"medical":[32],"therapy":[33],"(GDMT)":[34],"remain":[35],"uncertain.":[36],"Objective:":[37],"To":[38],"evaluate":[39],"real-world":[40],"outcomes":[41],"associated":[42,200,254,265,287],"H-ISDN":[44,197,234,251,284,323,338],"initiation":[45,198,285],"among":[46],"adults":[47,71,277],"HFrEF":[49,279,329],"receiving":[50,280],"all":[51,185],"four":[52],"foundational":[53],"GDMT":[54,114,195,342,359],"classes,":[55],"including":[56],"a":[57,327,332],"prespecified":[58,240],"subgroup":[60],"analysis.":[61],"Methods:":[62],"We":[63],"queried":[64],"the":[65,155,239],"TriNetX":[66],"US":[67],"Collaborative":[68],"Network":[69],"\u226518":[72],"years":[73],"defined":[76],"by":[77,320],"ICD-10":[78],"I50.2":[79],"or":[80,260],"LVEF":[81],"\u226440%,":[82],"evidence":[84,188],"of":[85,189],"beta-blocker,":[86],"ARNI/ARB,":[87],"mineralocorticoid":[88],"receptor":[89],"antagonist,":[90],"therapy.":[94],"Patients":[95],"initiating":[96],"both":[97],"hydralazine":[98],"isosorbide":[100],"\u22651":[102],"month":[103],"meeting":[105],"quadruple-GDMT":[106],"criteria":[107],"were":[108,143,163,171,174,223,231,246],"compared":[109],"continuing":[112],"without":[115],"H-ISDN.":[116],"One-to-one":[117],"propensity":[118],"score":[119],"matching":[120],"used":[121],"demographics,":[122],"race,":[123],"cardiovascular":[124],"renal":[126],"comorbidities,":[127],"diabetes,":[128],"atrial":[129],"fibrillation,":[130],"ischemic":[131],"etiology,":[132],"acute":[133,206,269],"HF,":[134],"LVEF,":[135],"prior":[136],"ED/inpatient":[137],"utilization,":[138,292],"background":[140],"medications.":[141],"Outcomes":[142],"assessed":[144],"in":[145],"landmark":[146,158],"windows":[147],"beginning":[148],"30":[149],"days":[150,229],"index.":[152],"Results:":[153],"In":[154,238,276],"primary":[156],"90-day":[157],"analysis,":[159],"3,165":[160],"matched":[161,244],"pairs":[162,245],"analyzed.":[164],"Mean":[165],"age":[166],"was":[167,199,252,286,304],"62":[168],"years,":[169],"32%":[170],"female,":[172],"45%":[173],"Black,":[175],"61%":[176],"had":[177,181,187],"CKD,":[178],"65%":[180],"diabetes.":[182],"By":[183],"design,":[184],"GDMT.":[191],"Compared":[192],"alone,":[196],"higher":[202,232,267,289,307],"all-cause":[203,258],"mortality,":[204,290],"hospitalization,":[205,268],"HF":[207,270,291,308],"encounters,":[208,271],"AKI":[210],"at":[211,217,227,235,248],"90":[212,228],"days,":[213],"persistent":[215],"associations":[216],"1":[218,236,249],"year.":[219,237,250],"Hypotension":[220],"syncope":[222],"not":[224,253],"significantly":[225,256],"different":[226,257],"subgroup,":[242],"1,239":[243],"analyzed":[247],"mortality":[259,302],"myocardial":[261],"infarction,":[262],"remained":[264],"AKI,":[272,293],"syncope.":[274],"Conclusions:":[275],"GDMT,":[283],"hyperkalemia,":[294],"longer-term":[296],"hypotension/syncope.":[297],"Among":[298],"patients,":[300],"no":[301],"observed,":[305],"while":[306],"utilization":[309],"renal/electrolyte/syncope":[311],"events":[312],"persisted.":[313],"These":[314],"findings":[315],"may":[316,325],"reflect":[317],"residual":[318],"confounding":[319],"indication,":[321],"as":[322],"recipients":[324],"represent":[326],"sicker":[328],"phenotype;":[330],"however,":[331],"potential":[333],"harm":[334],"signal":[335],"from":[336],"layering":[337],"onto":[339],"modern":[340],"cannot":[343],"be":[344],"excluded.":[345],"Prospective":[346],"studies":[347],"are":[348],"needed":[349],"to":[350],"define":[351],"benefit,":[352],"safety,":[353],"optimal":[355],"patient":[356],"selection":[357],"optimization.":[360]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}